Apoptotic/Recombinogenic Endonuclease G is Regulated by Promoter Methylation and Histone Acetylation.

Xiaoying Wang,Volodymyr Tryndyak,Eugene O. Apostolovi,Xiaoyan Yin,Sudhir V. Shah,Igor P. Pogribny,Alexei G. Basnakian
DOI: https://doi.org/10.1096/fasebj.22.1_supplement.987.2
2008-01-01
Abstract:Apoptotic endonuclease G (EndoG) is a DNase/RNase that produces double‐stranded DNA breaks and promotes recombination. EndoG can be induced by cytotoxic stimuli, however, the mechanisms of transcriptional regulation of this protein is unknown. The present study was initiated by the analysis of promoter sequences of all known human apoptotic endonucleases. This analysis revealed that EndoG is the only endonuclease that contains a CpG island, a potential site for DNA methylation, in the promoter region. We then compared three human prostate cancer cell lines and showed that EndoG was highly expressed in 22Rv1 and LNCaP, and not expressed in PC3 cells. The expression of EndoG in these cell lines inversely correlated with EndoG promoter methylation and directly correlated sensitivity of the cells to cisplatin or etoposide. The silencing of EndoG by siRNA decreased DNA fragmentation measured by TUNEL assay. The global hypomethylation by 5‐aza‐2′‐deoxycytidine induced EndoG mRNA and protein expression in PC3 cells and increased the cells' sensitivity to cisplatin and etoposide. In addition, TSA, a histone deacetylase inhibitor, induced EndoG expression in 22Rv1 cells, while it had no such effect in PC3 cells. These data indicate that EndoG is regulated by methylation of its gene promoter, and partially by histone acetylation, and that it is essential for DNA damage‐mediated cell death.
What problem does this paper attempt to address?